Lara Sullivan - Sep 11, 2023 Form 4 Insider Report for Pyxis Oncology, Inc. (PYXS)

Signature
/s/ Pamela Connealy, Attorney-in-Fact for Lara Sullivan
Stock symbol
PYXS
Transactions as of
Sep 11, 2023
Transactions value $
-$456,801
Form type
4
Date filed
9/13/2023, 08:16 PM
Previous filing
Sep 8, 2023
Next filing
Sep 18, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PYXS Common Stock Sale -$45.4K -20K -0.76% $2.27 2.61M Sep 11, 2023 Direct F1, F2
transaction PYXS Common Stock Sale -$11.1K -4.92K -0.19% $2.25 2.6M Sep 12, 2023 Direct F1, F3
transaction PYXS Common Stock Sale -$6.82K -3K -0.12% $2.27 2.6M Sep 13, 2023 Direct F1, F4
transaction PYXS Common Stock Tax liability -$394K -185K -7.11% $2.13 2.41M Sep 13, 2023 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects sales of common stock executed in multiple transactions. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected within the ranges set forth in footnotes 2 through 4 of this Form 4.
F2 The transaction was executed in multiple trades in prices ranging from $2.13 to $2.36.
F3 The transaction was executed in multiple trades in prices ranging from $2.21 to $2.30.
F4 The transaction was executed in multiple trades in prices ranging from $2.25 to $2.34.
F5 Represents shares withheld to cover taxes due upon the vesting of certain restricted stock units.